Reporter Sept 27 2013
Early cell death in MS
Oct. 2, 2013—Death of oligodendrocytes, the cells that make myelin, appears to be an early event in the development of multiple sclerosis.
Gene interactions and cavities
Sep. 30, 2013—Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay.
Metabolic profiling of vision loss
Sep. 27, 2013—A panel of metabolites – small molecules that are part of metabolic processes – that are unique to macular degeneration will shed light on the disease and aid diagnosis.
Cell changes en route to stomach cancer
Sep. 26, 2013—Molecular characterization of pre-cancerous changes in cells lining the stomach could point to lesions with a greater risk of progression to cancer.
Flulapalooza 3
Sep. 26, 2013—Vanderbilt faculty, staff and students turned out in droves and rolled up their sleeves for Wednesday’s Flulapalooza 3 mass vaccination event.
VU’s technology commercialization efforts make strides
Sep. 26, 2013—Over the past three years, Vanderbilt University more than quadrupled earnings from its technology commercialization efforts — to more than $24.5 million in the 2013 fiscal year that ended June 30, officials have announced.
Vaccine Research Program lands major NIH renewal
Sep. 26, 2013—The Vanderbilt Vaccine Research Program has received a major contract from the National Institutes of Health to continue its work as one of the nation’s Vaccine and Treatment Evaluation Units.
Sosman named one of ‘hottest’ researchers in U.S.
Sep. 26, 2013—Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch.
Age doesn’t impact concussion symptoms: study
Sep. 26, 2013—Recent scientific findings have raised the fear that young athletes may fare worse after sustaining a sports-related concussion than older athletes.
Stark to direct rehab services at Children’s Hospital
Sep. 26, 2013—Stacy Stark, D.O., has been named medical director of Pediatric Rehabilitation Services at the Monroe Carell Jr. Children’s Hospital at Vanderbilt. She is also assistant professor of Physical Medicine and Rehabilitation (PM&R).
Discovery Lecturer explores genome medicine’s impact
Sep. 26, 2013—We’re on a potential collision course, said last week’s Flexner Discovery Lecturer, between the delivery of good medical care and the possibilities offered by genome medicine.
Noted science writer Zimmer set for next Discovery Lecture
Sep. 26, 2013—Award-winning New York Times science writer and columnist Carl Zimmer will deliver the next Flexner Discovery Lecture on Thursday, Oct. 3, on setting science “right” when it goes “wrong.”
